- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2017
- Public Summary Document (PSD) November 2017 PBAC Meeting - PDF
- Public Summary Document (PSD) November 2017 PBAC Meeting - Word
Golimumab (ulcerative colitis) – November 2017
Golimumab (ulcerative colitis): Injection 100 mg in 1 mL single use pre-filled syringe/injection dev
Last updated
2 March 2018